A variety of markers (including CD68, CD163, CD204, HLA-DR, etc.)were used to identify different types of TAMs and the micro-distribution (in the tumor islet, stroma, or both) of TAMs in the tumor tissues [15–19]. This evidence concerns the gene CD163 and neoplasm.